What is the Share Price of Gennex Laboratories Ltd?

Gennex Laboratories Ltd share price is ₹12.57 As on 09 May, 2025|09:06

Home
>
Stocks
>
Gennex Laboratories Ltd

Gennex Laboratories Ltd Share Price

Q: What is the Market Cap of Gennex Laboratories Ltd?

The Market Cap of Gennex Laboratories Ltd is ₹286 As on 09 May, 2025|09:06

Q: What is PE Ratio of Gennex Laboratories Ltd?

The P/E ratio of Gennex Laboratories Ltd is 18.5 As on 09 May, 2025|09:06

Q: What is PB Ratio of Gennex Laboratories Ltd?

The PB ratio of Gennex Laboratories Ltd is 4.29 As on 09 May, 2025|09:06

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 1

Cons 9

Gennex Laboratories Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 12.57 down by -0.55%. The total volume of shares on NSE and BSE combined was 243,135 shares. Its total combined turnover was Rs 0.31 crores.

Gennex Laboratories Ltd Medium and Long Term Market Action

The stock price of Gennex Laboratories Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Gennex Laboratories Ltd Fundamentals

Market Cap (Cr): 286
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Gennex Laboratories Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Gennex Laboratories Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Gennex Laboratories Ltd

Data not available.

Gennex Laboratories Ltd FAQ's

What is Share Price of Gennex Laboratories Ltd?

What is the Market Cap of Gennex Laboratories Ltd?

What is PE Ratio of Gennex Laboratories Ltd?

What is PB Ratio of Gennex Laboratories Ltd?

What is the CAGR of Gennex Laboratories Ltd?

How to Buy Gennex Laboratories Ltd Share?

Can I buy Gennex Laboratories Ltd from Samco?

How do I buy Gennex Laboratories Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.01. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -194.12% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 87.80 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 189 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.
High Promoter Pledge
The company has a relatively high promoter pledge to the extent of 24% of the total company's shareholding which can have a significantly negative impact on stock.

Valuation Analysis

Margin of safety
(09/05/2025)

102

Margin of Safety Index: High

66.67%

66.67% People are bullish about Gennex Laboratories Ltd

33.33%

33.33 % People are bearish about Gennex Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %